Biotech Breakthroughs
Exciting advancements in biotechnology are reshaping the treatment landscape, with over 256 new medicines approved in the last five years alone. The emergence of gene therapies, particularly for conditions like hemophilia and muscular dystrophy, highlights the industry's potential to address significant unmet medical needs. However, the path to commercial success remains fraught with challenges, as 90% of therapies that enter clinical trials never reach the market, making strategic investment crucial.In this clip
From this podcast
Capital Allocators – Inside the Institutional Investment Industry
Andy Acker - Empty Rooms: Investing in Biotech at Janus Henderson (Capital Allocators, EP.274)
Related Questions